Not applicableStudy completedNCT01268241
What this trial is testing
The Efficacy and Safety of Switch Between Agalsidase Beta to Agalsidase Alfa for Enzyme Replacement in Patients With Anderson-Fabry Disease
Who this might be right for
Fabry DiseaseFabry´s DiseaseAnderson-Fabry Disease
CENTOGENE GmbH Rostock 200